Cargando…

Novel preoperative nutritional assessment tool and prognostic model for ESCC patients

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive tumor types worldwide, and malnutrition prevails in these patients. However, there is no preoperative nutritional assessment tool specifically designed for patients with ESCC. Methods: Patients who received esophagec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinming, Cao, Jinlin, Wang, Ying, Yao, Xin, Wang, Yiqing, He, Zhehao, Lv, Wang, Hu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692628/ https://www.ncbi.nlm.nih.gov/pubmed/31417631 http://dx.doi.org/10.7150/jca.31286

Ejemplares similares

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients
por: Cao, Honggang, et al.
Publicado: (2023)

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction
por: Xu, Jinming, et al.
Publicado: (2017)

Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
por: Cao, Jinlin, et al.
Publicado: (2018)

Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC
por: Gao, Hongyun, et al.
Publicado: (2012)

Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review
por: Tianxing, Guo, et al.
Publicado: (2019)

Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients
por: Xu, Jinming, et al.
Publicado: (2017)

The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC)
por: Zhou, Xia, et al.
Publicado: (2017)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC
por: Kong, Pengzhou, et al.
Publicado: (2020)

Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes
por: Zhang, Chong, et al.
Publicado: (2021)

Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis
por: Tang, Lu, et al.
Publicado: (2020)

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients
por: Zhang, Cui-Ying, et al.
Publicado: (2019)

Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC)
por: Song, Guiqin, et al.
Publicado: (2019)

UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines
por: Palumbo, Antonio, et al.
Publicado: (2016)

The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter
por: Liu, Qian, et al.
Publicado: (2019)

LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis
por: Jia, Jinlin, et al.
Publicado: (2021)

Prognosis and Progression of ESCC Patients with Perineural Invasion
por: Xu, Guanghui, et al.
Publicado: (2017)

Using preoperative control nutritional status scores as prognostic factors for endometrial cancer
por: Yuan, Jing, et al.
Publicado: (2023)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

Does a thoracoscopic approach provide better outcomes for pulmonary metastases?
por: Rusidanmu, Aizemaiti, et al.
Publicado: (2021)

ATF3 suppresses ESCC via downregulation of ID1
por: Li, Jian, et al.
Publicado: (2016)

Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization
por: Li, Shengwei, et al.
Publicado: (2021)

Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition
por: Wang, Xuexiao, et al.
Publicado: (2017)

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC
por: Yang, Jie, et al.
Publicado: (2018)

Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC
por: Wang, Qiu‐Yu, et al.
Publicado: (2020)

A Simple Method to Train the AI Diagnosis Model of Pulmonary Nodules
por: He, Zhehao, et al.
Publicado: (2020)

Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC
por: Ma, Yuanyuan, et al.
Publicado: (2021)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

Reply: Hookah, opium, and tobacco smoking in relation to ESCC
por: Malekzadeh, R, et al.
Publicado: (2009)

Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC
por: Sun, Ying, et al.
Publicado: (2021)

How we assess the perioperative anxiety of surgical patients with pulmonary nodules: the revision of state-trait anxiety inventory
por: Zhou, Zhenyu, et al.
Publicado: (2020)

Prognostic Value of Preoperative Nutritional Assessment and Neutrophil-to-Lymphocyte Ratio in Patients With Thymic Epithelial Tumors
por: Huang, Yang-Yu, et al.
Publicado: (2022)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial: A randomized clinical trial of neoadjuvant therapy for ESCC
por: Li, Yong, et al.
Publicado: (2023)

Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC
por: Luo, Yuejun, et al.
Publicado: (2022)

The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells
por: Zhang, Xiao-Dan, et al.
Publicado: (2018)

Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16
por: Liang, Lily, et al.
Publicado: (2023)

Artificial Intelligence for Detecting and Delineating Margins of Early ESCC Under WLI Endoscopy
por: Liu, Wei, et al.
Publicado: (2022)

Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
por: Wang, Minmin, et al.
Publicado: (2021)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_77tb846h2p34u7imrri5m9gl3j